Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Medical Condition: Ulcerative Colitis MedDRA version: 20.1Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Ulcerative+Colitis+MedDRA+version%3A+20.1Level%3A+LLTClassification+code+10045365Term%3A+Ulcerative+colitisSystem+Organ+Class%3A+100000004856%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Digestive+System+Diseases+%5BC06%5D%22
/vufind/Search/Results?lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Ulcerative+Colitis+MedDRA+version%3A+20.1Level%3A+LLTClassification+code+10045365Term%3A+Ulcerative+colitisSystem+Organ+Class%3A+100000004856%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Digestive+System+Diseases+%5BC06%5D%22
Search /vufind/Search2/Results?lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Ulcerative+Colitis+MedDRA+version%3A+20.1Level%3A+LLTClassification+code+10045365Term%3A+Ulcerative+colitisSystem+Organ+Class%3A+100000004856%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Digestive+System+Diseases+%5BC06%5D%22
PubPharm (86)
1
Phase 2 Dose-finding IMU-838 for Ulcerative Colitis (CALDOSE-1) : A phase 2, multicenter, randomized, double-blind, placebo-controlled, dose-finding study to evaluate the efficacy and safety of IMU-838 for induction and maintenance therapy in moderate-to-severe ulcerative colitis CALDOSE-1
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Phase 2 Dose-finding IMU-838 for Ulcerative Colitis (CALDOSE-1) : A phase 2, multicenter, randomized, double-blind, placebo-controlled, dose-finding study to evaluate the efficacy and safety of IMU-838 for induction and maintenance therapy in moderate-to-severe ulcerative colitis CALDOSE-1
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Phase 2 Dose-finding IMU-838 for Ulcerative Colitis (CALDOSE-1) : A phase 2, multicenter, randomized, double-blind, placebo controlled, dose-finding study to evaluate the efficacy and safety of IMU 838 for induction and maintenance therapy in moderate-to-severe ulcerative colitis CALDOSE-1
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
4
Phase 2 Dose-finding IMU-838 for Ulcerative Colitis (CALDOSE-1) : A phase 2, multicenter, randomized, double-blind, placebo controlled, dose-finding study to evaluate the efficacy and safety of IMU 838 for induction and maintenance therapy in moderate-to-severe ulcerative colitis CALDOSE-1
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
5
Phase 2 Dose-finding IMU-838 for Ulcerative Colitis (CALDOSE-1) : A phase 2, multicenter, randomized, double-blind, placebo controlled, dose-finding study to evaluate the efficacy and safety of IMU 838 for induction and maintenance therapy in moderate-to-severe ulcerative colitis CALDOSE-1
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
6
Phase 2 Dose-finding IMU-838 for Ulcerative Colitis (CALDOSE-1) : A phase 2, multicenter, randomized, double-blind, placebo controlled, dose-finding study to evaluate the efficacy and safety of IMU 838 for induction and maintenance therapy in moderate-to-severe ulcerative colitis CALDOSE-1
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
7
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis : A 54-Week Treatment, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo and Active-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy and Safety of Brazikumab in Participants with Moderately to Severely Active Ulcerative Colitis - Phase 2 Dose-finding UC Study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
8
A study of PRA023 in patients with Ulcerative Colitis : A Phase 2, Multi-Center, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Induction Therapy with PRA023 in Subjects with Moderately to Severely Active Ulcerative Colitis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
9
A study of LY3471851 in adult participants with moderately to severely active ulcerative colitis (UC) : An Adaptive Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY3471851 (NKTR-358) in Patients with Moderately to Severely Active Ulcerative Colitis - INSTRUCT-UC
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
10
Open-label Extension Study of Brazikumab in Ulcerative Colitis : A Phase 2 Open-label, Long-term Extension Safety Study of Brazikumab in Participants with Moderately to Severely Active Ulcerative Colitis (EXPEDITION OLE) - EXPEDITION OLE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
1
2
3
4
5
6
7
8
9
Nächster »
[9]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Medical Condition: Ulcerative Colitis MedDRA version: 20.1Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Medienart
86
Aufsätze
86
E-Artikel
86
E-Ressourcen
Zeitschriftentitel
86
WHO International Clinical Trials Registry Plat...
Thema
86
610
Medical Condition: Ulcerative Colitis MedDRA ve...
86
Recruitment Status: Authorised-recruitment may ...
86
Study Type: Interventional
64
Phase: Phase 2
20
Phase: Phase 3
2
Phase: Phase 4
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
78
2020-
8
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
84
Englisch
2
Unbestimmt
Haven't found what you're looking for?
Wird geladen...